Literature DB >> 11710716

Antisense inhibition of CD44 tailless splice variant in human articular chondrocytes promotes hyaluronan internalization.

H Jiang1, C B Knudson, W Knudson.   

Abstract

OBJECTIVE: To determine whether alternatively spliced variants of CD44, in particular a short, intracellular tail CD44 isoform, are used by articular chondrocytes to modulate the functions of this matrix receptor.
METHODS: Normal human articular chondrocytes were cultured with or without interleukin-1alpha (IL-1alpha), and the relative expression of CD44 exon 19 and CD44 exon 20, hyaluronan synthase 2, aggrecan, and GAPDH messenger RNA (mRNA) was determined using reverse transcriptase-polymerase chain reaction. Next, CD44 exon 19 mRNA was selectively inhibited by the use of antisense oligonucleotides. The effects of exon 19 loss were analyzed by matrix assembly and hyaluronan internalization assays.
RESULTS: Human articular chondrocytes express varying levels of exon 19 (short tail)- and exon 20 (long tail)-containing CD44 mRNA. Both CD44 mRNA are up-regulated by IL-1alpha. Selective inhibition of CD44 exon 19 results in enhanced hyaluronan internalization and smaller cell-associated matrices.
CONCLUSION: The expression of a natural CD44 decoy-like receptor by articular chondrocytes modulates the function of this matrix receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710716     DOI: 10.1002/1529-0131(200111)44:11<2599::aid-art440>3.0.co;2-y

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis.

Authors:  Sai P Thankamony; Warren Knudson
Journal:  J Biol Chem       Date:  2006-08-30       Impact factor: 5.157

Review 2.  The pericellular hyaluronan of articular chondrocytes.

Authors:  Warren Knudson; Shinya Ishizuka; Kenya Terabe; Emily B Askew; Cheryl B Knudson
Journal:  Matrix Biol       Date:  2018-02-06       Impact factor: 11.583

3.  Extracellular processing of the cartilage proteoglycan aggregate and its effect on CD44-mediated internalization of hyaluronan.

Authors:  Ben T Danielson; Cheryl B Knudson; Warren Knudson
Journal:  J Biol Chem       Date:  2015-03-02       Impact factor: 5.157

4.  Acidification of Tumor at Stromal Boundaries Drives Transcriptome Alterations Associated with Aggressive Phenotypes.

Authors:  Nazanin Rohani; Liangliang Hao; Maria S Alexis; Brian A Joughin; Konstantin Krismer; Mira N Moufarrej; Anthony R Soltis; Douglas A Lauffenburger; Michael B Yaffe; Christopher B Burge; Sangeeta N Bhatia; Frank B Gertler
Journal:  Cancer Res       Date:  2019-02-12       Impact factor: 12.701

5.  Internalization of aggrecan G1 domain neoepitope ITEGE in chondrocytes requires CD44.

Authors:  Wataru Ariyoshi; Cheryl B Knudson; Na Luo; Amanda J Fosang; Warren Knudson
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

6.  Interleukin-1β-induced Reduction of CD44 Ser-325 Phosphorylation in Human Epidermal Keratinocytes Promotes CD44 Homomeric Complexes, Binding to Ezrin, and Extended, Monocyte-adhesive Hyaluronan Coats.

Authors:  Tiina Jokela; Sanna Oikari; Piia Takabe; Kirsi Rilla; Riikka Kärnä; Markku Tammi; Raija Tammi
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

7.  Identification and molecular characterization of a novel splice variant of human 5- lipoxygenase gene.

Authors:  Abhay Kumar Singh; Rahul Kumar; Abhay Anand Shukla; Gururao Hariprasad; Shyam Sunder Chauhan; Sharmistha Dey
Journal:  Mol Biol Rep       Date:  2014-09-14       Impact factor: 2.316

8.  CD44 modulates Smad1 activation in the BMP-7 signaling pathway.

Authors:  Richard S Peterson; Roma A Andhare; Kathleen T Rousche; Warren Knudson; Weihua Wang; Jami B Grossfield; Raymond O Thomas; Robert E Hollingsworth; Cheryl B Knudson
Journal:  J Cell Biol       Date:  2004-09-27       Impact factor: 10.539

9.  Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells.

Authors:  Mitsuo Nishiyama; Ryouichi Tsunedomi; Kiyoshi Yoshimura; Noriaki Hashimoto; Satoshi Matsukuma; Hiroyuki Ogihara; Shinsuke Kanekiyo; Michihisa Iida; Kazuhiko Sakamoto; Nobuaki Suzuki; Shigeru Takeda; Shigeru Yamamoto; Shigefumi Yoshino; Tomio Ueno; Yoshihiko Hamamoto; Shoichi Hazama; Hiroaki Nagano
Journal:  Cancer Sci       Date:  2018-03-06       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.